Dipòsit Digital de Documents de la UAB 11 registres trobats  1 - 10següent  anar al registre: La cerca s'ha fet en 0.01 segons. 
1.
9 p, 923.4 KB Synaptic proteomics as a means to identify the molecular basis of mental illness : Are we getting there? / Reig-Viader, R (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sindreu, Carlos (Universitat de Barcelona) ; Bayés, Àlex (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Synapses are centrally involved in many brain disorders, particularly in psychiatric and neurodevelopmental ones. However, our current understanding of the proteomic alterations affecting synaptic performance in the majority of mental illnesses is limited. [...]
2018 - 10.1016/j.pnpbp.2017.09.011
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 84 (august 2018) , p. 353-361  
2.
9 p, 280.6 KB Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder : A Prospective Study on the Effects of Time / Ferrer Vinardel, Marc (Hospital Universitari Vall d'Hebron) ; Soto-Angona, Óscar (Hospital Universitari Vall d'Hebron) ; Soler Artigas, María (Hospital Universitari Vall d'Hebron) ; Ibáñez, Pol (Hospital Universitari Vall d'Hebron) ; Fadeuilhe, Christian (Hospital Universitari Vall d'Hebron) ; Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ; Lidai, Raquefet (Hospital Universitari Vall d'Hebron) ; Vargas-Cáceres, Sebastian (Hospital Universitari Vall d'Hebron) ; Torrecilla, María Ángeles (Hospital Universitari Vall d'Hebron) ; López Illamola, Anna (Hospital Universitari Vall d'Hebron) ; Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Agitation in patients diagnosed with personality disorders (PD) is one of the most frequent crises in emergency departments (ED). Although many medications have been tested, their effectiveness has been small or non-significant, and no specific drugs are supported by the available evidence. [...]
2022 - 10.9758/cpn.2022.20.3.482
Clinical Psychopharmacology and Neuroscience, Vol. 20 (august 2022) , p. 482-490  
3.
24 p, 905.3 KB Intra-hippocampal d-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats / Portero Tresserra, Marta (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Martí Nicolovius, Margarita (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Tarrés-Gatius, Mireia (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Candalija Iserte, Ana (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Guillazo i Blanch, Gemma (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Vale Martínez, Anna (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Universitat Autònoma de Barcelona. SGR-Grup de Recerca Potenciació i Recuperació de la Memòria en Rates normals i amb Dany Cerebral
Aging is characterized by a decrease in N-methyl-D-aspartate receptors (NMDARs) in the hippocampus, which might be one of the factors involved in the age-dependent cognitive decline. D-Cycloserine (DCS), a partial agonist of the NMDAR glycine recognition site, could improve memory deficits associated to neurodegenerative disorders and cognitive deficits observed in normal aging. [...]
2018 - 10.1007/s00213-018-4858-z
Psychopharmacology, Vol. 235 Núm. 5 (2018) , p. 1463-1477  
4.
14 p, 1.2 MB Daidzein modulates cocaine-reinforcing effects and cue-induced cocaine reinstatement in CD-1 male mice / Martin, Miquel (Universitat Pompeu Fabra. Parc de Recerca Biomèdica de Barcelona) ; Gutiérrez-Martos, Miriam (Universitat Pompeu Fabra. Parc de Recerca Biomèdica de Barcelona) ; Cabrera, Roberto (Universitat Pompeu Fabra. Parc de Recerca Biomèdica de Barcelona) ; Langohr, Klaus (Universitat Politècnica de Catalunya. Departament d'Estadística i Investigació Operativa) ; Maldonado, Rafael 1961- (Universitat Pompeu Fabra) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; De La Torre, Rafael (Universitat Pompeu Fabra) ; Universitat Autònoma de Barcelona
Cocaine addiction is a chronic relapsing disorder that lacks of an effective treatment. Isoflavones are a family of compounds present in different plants and vegetables like soybeans that share a common chemical structure. [...]
2021 - 10.1007/s00213-021-05820-z
Psychopharmacology, Vol. 238 (april 2021) , p. 1923-1936  
5.
11 p, 314.7 KB The safety of agomelatine in standard medical practice in depressed patients : A 26-week international multicentre cohort study / Gorwood, Philip (Université de Paris & INSERM U1266) ; Benichou, Jacques (Unité de Biostatistiques. Centre Hospitalier Universitaire de Rouen) ; Moore, Nicholas (Bordeaux PharmacoEpi CIC Bordeaux CIC1401 INSERM U1219 Hôpital Pellegrin) ; Álvarez, Enrique (Álvarez Martínez) (Institut d'Investigació Biomèdica Sant Pau) ; Mertens, Joost (De Velse GGZ) ; Aguglia, Eugenio (AOU Policlinico Vittorio-Emanuele. Clinica Psichiatrica) ; Figueira, Maria-Luisa (University of Lisbon) ; Falkai, Peter (University of Munich) ; Olivier, Valérie (Institut de Recherches Internationales Servier (IRIS)) ; Wattez, Marine (Institut de Recherches Internationales Servier (IRIS)) ; Picarel-Blanchot, Françoise (Institut de Recherches Internationales Servier (IRIS)) ; de Bodinat, Christian (Institut de Recherches Internationales Servier (IRIS)) ; Universitat Autònoma de Barcelona
The present observational cohort study documented the safety of agomelatine in current medical practice in out-patients suffering from major depressive disorder. The 6-month evolution of agomelatine-treated patients was assessed with a focus on safety (emergent adverse events, liver acceptability), severity of depression using the Clinical Global Impression Severity (CGI-S) score, and functioning measured by the Sheehan Disability Scale (SDS). [...]
2020 - 10.1002/hup.2759
Human Psychopharmacology, Vol. 36 (september 2020)  
6.
20 p, 543.7 KB The association between hormones and antipsychotic use : a focus on postpartum and menopausal women / González-Rodríguez, Alexandre (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Seeman, Mary (University of Toronto. Department of Psychiatry)
During the postpartum and menopausal periods of women's lives, there is a well-established and significant drop of circulating estrogens. This may be the reason why both these periods are associated with an increased risk for onset or exacerbation of psychiatric disorders. [...]
2019 - 10.1177/2045125319859973
Therapeutic Advances in Psychopharmacology, Vol. 9 (july 2019)  
7.
9 p, 287.3 KB Psychopathological symptoms associated with synthetic cannabinoid use : a comparison with natural cannabis / Mensen, Vincent T. (Department of Drug Monitoring, Utrecht, The Netherlands) ; Vreeker, Annabel (University of Utrecht. University Medical Center Utrecht, Department of Psychiatry) ; Nordgren, Johan (Malmö University. Department of Social Work) ; Atkinson, Amanda (Liverpool John Moores University. Public Health Institute) ; De La Torre, Rafael (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ramaekers, Johannes G. (Maastricht University. Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience) ; Brunt, Tibor M. (Radboud University. Department of Developmental Psychopathology) ; Universitat Autònoma de Barcelona
Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many different synthetic cannabinoid analogues are on the consumer market and sold under misleading names, like "spice" or "incense. [...]
2019 - 10.1007/s00213-019-05238-8
Psychopharmacology, Vol. 236 (april 2019) , p. 2677-2685  
8.
12 p, 532.4 KB Therapeutic potential of ayahuasca in grief : a prospective, observational study / González, Débora (International Center for Ethnobotanical Education, Research and Services (ICEERS)) ; Cantillo, Jordi (International Center for Ethnobotanical Education, Research and Services (ICEERS)) ; Pérez, Irene (International Center for Ethnobotanical Education, Research and Services (ICEERS)) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Feilding, Amanda (The Beckley Foundation) ; Obiols Llandrich, Jordi (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ; Bouso, José Carlos (International Center for Ethnobotanical Education, Research and Services (ICEERS))
Recent studies have assessed the therapeutic potential of ayahuasca for the treatment of depression with promising preliminary results. Here, we examine the course of grief over 1 year of follow-up in a bereaved sample that attended a center in Peru to participate in indigenous Shipibo ayahuasca ceremonies. [...]
2020 - 10.1007/s00213-019-05446-2
Psychopharmacology, Vol. 237 (january 2020) , p. 1171-1182  
9.
9 p, 609.8 KB Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication / Haijen, E. (Maastricht, The Netherlands) ; Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; De La Torre, Rafael (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pastor, A. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Olesti, Eulàlia (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pizarro, N. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ramaekers, Johannes G (Maastricht, The Netherlands) ; Kuypers, Kim P. C (Maastricht University. Department of Neuropsychology and Psychopharmacology)
Preclinical data have suggested involvement of the endocannabinoid (eCB) system in MDMA-induced memory impairment. Clinical research has shown that blockade of the 5-HT receptor nulls memory impairment during MDMA intoxication. [...]
2017 - 10.1007/s00213-017-4787-2
Psychopharmacology, Vol. 235 (november 2017) , p. 709-717  
10.
10 p, 560.4 KB MDMA-induced indifference to negative sounds is mediated by the 5-HT receptor / Kuypers, Kim P. C (Maastricht University. Department of Neuropsychology and Psychopharmacology) ; De La Torre, Rafael (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farre, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pizarro, N. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Xicota, Laura (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ramaekers, Johannes G (Maastricht, the Netherlands)
MDMA has been shown to induce feelings of sociability, a positive emotional bias and enhanced empathy. While previous research has used only visual emotional stimuli, communication entails more than that single dimension and it is known that auditory information is also crucial in this process. [...]
2017 - 10.1007/s00213-017-4699-1
Psychopharmacology, Vol. 235 (july 2017) , p. 481-490  

Dipòsit Digital de Documents de la UAB : 11 registres trobats   1 - 10següent  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.